Vanguard holds 1.69M shares (5.23%) of IRhythm
Vanguard Capital Management reported beneficial ownership of 1,691,483 shares of IRhythm Holdings Inc. common stock, equal to 5.23% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vanguard Capital Management reported beneficial ownership of 1,691,483 shares of IRhythm Holdings Inc. common stock, equal to 5.23% of the class. The filer reports sole voting power over 245,773 shares and sole dispositive power over 1,691,483 shares. The filing is signed by Ashley Grim on 04/27/2026.
Insights
Vanguard's 5.23% stake is a standard Schedule 13G passive disclosure for a large asset manager.
Schedule 13G filings show beneficial ownership by investors who claim passive intent under SEC rules. The filing lists concrete control metrics: 1,691,483 shares beneficially owned and 245,773 shares with sole voting power.
Cash‑flow treatment and sale intent are not stated; future Form 13D or Form 4 filings would signal active engagement. Timing shown: signature date 04/27/2026.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power regulatory
Investment Company Act of 1940 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management hold in IRhythm (IRTC)?
Does the Schedule 13G indicate Vanguard will actively influence IRhythm?
Who certified the filing and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.